WCLC 2025 - Posters & ePosters-P3.12.63 MTAPloss Is Frequent and Potentially Targetable With PRMT5 Inhibitors in Oncogene-Driven NSCL

P3.12.63 MTAPloss Is Frequent and Potentially Targetable With PRMT5 Inhibitors in Oncogene-Driven NSCL

Asset Subtitle

Mihaela Aldea

Meta Tag

Speaker Mihaela Aldea

Topic Metastatic Non-small Cell Lung Cancer – Targeted Therapy